William H. Rastetter
At a glance: William H. Rastetter is Director at Dare Bioscience (DARE). Their latest SEC Form 4, filed Nov 20, 2026, reported a sale of $382. On file: 0 purchase lines ($0) and 2 sale lines ($2.7M).
Director at Dare Bioscience, Inc. (DARE); Director at Neurocrine Biosciences Inc (NBIX)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
William H. Rastetter's InsiderPrint
2 trades from SEC Form 4 filings, 2025 to 2026, drawn as one fingerprint.
- Bump outward: a purchase (0)
- Dent inward: a sale (2)
- One ring per year, oldest in the middle, Jan at the top going clockwise. Bigger bumps mean more dollars.
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Nov 20 NewSEC | DAREDare Bioscience, Inc. | Sell | 859 | $0.45 | $382 | — |
| Nov 6SEC | NBIXNeurocrine Biosciences Inc | Sell Plan | 18,00040,360 held (−31%) | $151.82 | $2.7M | +3.6% |
- Sell
Director William H Rastetter sold $2.7M of NBIX at $151.82 — cuts the stake by 31%; pre-scheduled 10b5-1 plan sale.
Follow William H. Rastetter
Get one email when William H. Rastetter files a new purchase or sale. Free.
At most one email a day about William H. Rastetter, plus the free Monday email. Already subscribed? Use the same email to add them. Unsubscribe anytime. Facts from public filings, not advice.